# Abatacept in Juvenile Dermatomyositis

> **NCT02594735** · PHASE4 · COMPLETED · sponsor: **George Washington University** · enrollment: 10 (actual)

## Conditions studied

- Dermatomyositis

## Interventions

- **DRUG:** Abatacept

## Key facts

- **NCT ID:** NCT02594735
- **Lead sponsor:** George Washington University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2021-07-16
- **Final completion:** 2021-10-22
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02594735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02594735, "Abatacept in Juvenile Dermatomyositis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02594735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*